{"company":{"id":3780304,"name":"Sail Biomedicines","domain":"sail.bio","url":"https://alion.io/company/sail-6"},"section":"news","answer":"Sail Biomedicines: 20 headlines on record, 2 headlines in the last 90 days. Its story counts 3 milestones.","figures":[{"label":"Headlines","value":"20"},{"label":"In 90 days","value":"2"},{"label":"Milestones","value":"3"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":19},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":3}],"news":[{"date":"2026-09-29","kind":"News","title":"Moving CAR-T Beyond Oncology PharmExec","source":"pharmexec.com","url":"https://pharmexec.com/view/moving-cart-beyond-oncology"},{"date":"2026-09-29","kind":"News","title":"M&A Roundup: Johnson & Johnson Collaborates with Sail Biomedicines, Processa Pharmaceuticals Acquires Vidya Therapeutics, Relation Collaborates with GSK PharmExec","source":"pharmexec.com","url":"https://pharmexec.com/view/roundup-johnson-collaborates-sail-processa-acquires-vidya-relation-gsk"},{"date":"2026-08-02","kind":"News","title":"Johnson & Johnson Secures $2.58 Billion Option To Acquire Sail Biomedicines","source":"Pulse 2.0","url":"https://pulse2.com/johnson-johnson-secures-2-58-billion-option-to-acquire-sail-biomedicines/"},{"date":"2026-07-31","kind":"News","title":"J&J collaborates with Sail Biomedicines to advance in vivo CAR-T programmes and transform autoimmune disease via immune reset","source":"pharmabiz.com","url":"https://pharmabiz.com/NewsDetails.aspx?aid=187599&amp;sid=2"},{"date":"2026-07-30","kind":"News","title":"Sail Biomedicines Announces Strategic Collaboration to Develop New Class of Medicines for In Vivo CAR-T","source":"YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/sail-biomedicines-announces-strategic-collaboration-214500823.html"},{"date":"2026-04-27","kind":"News","title":"Sail Biomedicines to Present Preclinical Data Supporting Advancement of Its In Vivo eRNA CAR-T Product Candidate to the Clinic at ASGCT 2026 and TIDES USA 2026","source":"YahooFinance","url":"https://finance.yahoo.com/sectors/healthcare/articles/sail-biomedicines-present-preclinical-data-203000973.html"},{"date":"2026-03-24","kind":"News","title":"In The News Bringing RNA Therapies Full Circle with Transient CAR T Drug Discovery News March 24, 2026","source":"drugdiscoverynews.com","url":"https://drugdiscoverynews.com/bringing-rna-therapies-full-circle-with-transient-car-t-17082"},{"date":"2025-12-12","kind":"News","title":"RNA that lasts longer and lands exactly where it should","source":"Drug Target Review","url":"https://drugtargetreview.com/rna-that-lasts-longer-and-lands-exactly-where-it-should/681147.article"},{"date":"2025-11-04","kind":"News","title":"In The News Circular RNA: The Next Frontier for RNA Therapeutics? Technology Networks November 4, 2025","source":"technologynetworks.com","url":"https://technologynetworks.com/biopharma/blog/circular-rna-the-next-frontier-for-rna-therapeutics-406510"},{"date":"2025-06-02","kind":"Press release","title":"Sail Biomedicines to Present New Preclinical Data on Malaria eRNA Vaccine Candidates at the 2025 Grand Challenges Annual Meeting","source":"businesswire.com","url":"https://businesswire.com/news/home/20250602031137/en/Sail-Biomedicines-to-Present-New-Preclinical-Data-on-Malaria-eRNA-Vaccine-Candidates-at-the-2025-Grand-Challenges-Annual-Meeting"},{"date":"2025-05-30","kind":"News","title":"Designing Our Way Toward Circular RNA Medicines With AI","source":"advancingrna.com","url":"https://advancingrna.com/doc/designing-our-way-toward-circular-rna-medicines-with-ai-0001"},{"date":"2025-05-13","kind":"News","title":"PRN_FinancialWrapper","source":"PRNewswire","url":"https://markets.financialcontent.com/prnews/article/bizwire-2025-5-13-sail-biomedicines-presents-preclinical-data-on-in-vivo-erna-car-t-candidate-for-autoimmune-diseases-at-asgct-2025"},{"date":"2025-05-13","kind":"Press release","title":"Press Release Sail Biomedicines Presents Preclinical Data on In Vivo eRNA CAR-T Candidate for Autoimmune Diseases at ASGCT 2025 BusinessWire May 13, 2025","source":"businesswire.com","url":"https://businesswire.com/news/home/20250512895131/en/Sail-Biomedicines-Presents-Preclinical-Data-on-In-Vivo-eRNA-CAR-T-Candidate-for-Autoimmune-Diseases-at-ASGCT-2025"},{"date":"2025-04-30","kind":"News","title":"Q&A: Is the key to personalised medicine programmability?","source":"European Pharmaceutical Manufacturer","url":"https://pharmaceuticalmanufacturer.media/pharmaceutical-industry-insights/latest-pharmaceutical-manufacturing-industry-insights/is-the-key-to-personalised-medicine-programmability/"},{"date":"2025-04-07","kind":"Press release","title":"Sail Biomedicines Appoints Laura Sepp-Lorenzino, Ph.D., to Its Board of Directors","source":"businesswire.com","url":"https://businesswire.com/news/home/20250407463046/en/Sail-Biomedicines-Appoints-Laura-Sepp-Lorenzino-Ph.D.-to-Its-Board-of-Directors/"},{"date":"2024-04-02","kind":"Press release","title":"Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board","source":"businesswire","url":"https://businesswire.com/news/home/20240402833623/en/Sail-Biomedicines-Appoints-Clinical-and-Scientific-Leader-Dr.-Wendy-Chung-to-Its-Board"},{"date":"2024-01-05","kind":"Press release","title":"Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines","source":"Nasdaq","url":"https://nasdaq.com/press-release/sail-biomedicines-provides-update-on-research-with-cystic-fibrosis-foundation-and"},{"date":"2024-01-05","kind":"Press release","title":"Press Release Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines Business Wire January 5, 2024","source":"businesswire.com","url":"https://businesswire.com/news/home/20240104246109/en/Sail-Biomedicines-Provides-Update-on-Research-with-Cystic-Fibrosis-Foundation-and-Pioneering-Medicines"},{"date":"2024-01-04","kind":"Press release","title":"Press Release Sail Biomedicines Appoints Tech and Pharma Industry Veteran Frank D'Amelio to Its Board Business Wire January 4, 2024","source":"businesswire.com","url":"https://businesswire.com/news/home/20240103813869/en/Sail-Biomedicines-Appoints-Tech-and-Pharma-Industry-Veteran-Frank-D%E2%80%99Amelio-to-Its-Board"}],"story":[{"title":"Partnership Sail Biomedicines Announces Strategic Collaboration to Develop New Class of Medicines for In Vivo CAR-T · morningstar.com","url":"https://morningstar.com/news/business-wire/20260728202837/sail-biomedicines-announces-strategic-collaboration-to-develop-new-class-of-medicines-for-in-vivo-car-t"},{"title":"Board appointment Sail Biomedicines Appoints Laura Sepp-Lorenzino, Ph.D., to Its Board of Directors · businesswire.com","url":"https://businesswire.com/news/home/20250407463046/en/Sail-Biomedicines-Appoints-Laura-Sepp-Lorenzino-Ph.D.-to-Its-Board-of-Directors/"},{"title":"Board appointment Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board · businesswire","url":"https://businesswire.com/news/home/20240402833623/en/Sail-Biomedicines-Appoints-Clinical-and-Scientific-Leader-Dr.-Wendy-Chung-to-Its-Board"}],"as_of":"2026-11-17","cite":"Sail Biomedicines, News. Alion, Nov 17, 2026. https://alion.io/company/sail-6/news","html_url":"https://alion.io/company/sail-6/news","json_url":"https://alion.io/company/sail-6/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T23:28:21Z"}}